NIH-funded research R03 grant

Osimertinib resistance and brain metastasis in lung cancer

Official title: Establishing pre-clinical models of osimertinib resistance-mediated brain metastasis

Funded at University of California, San Diego · NIH-11285092 · Data updated 2026-11-12

This grant aims to create animal models of osimertinib resistance that spread to the brain in lung cancer, to help scientists understand why some patients stop responding and develop brain tumors.

More Metastasis research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJuly 1, 2026
Project endJune 30, 2028
Funding year2026
Award (this year)$120,000
NIH project number1R03OD039968-01
Project IDNIH-11285092 on NIH RePORTER

Who could benefit from this research

Could help

Patients with non-small cell lung cancer who develop resistance to osimertinib and/or brain metastases.

Less likely to help

This basic research study does not directly enroll patients; however, it relies on patient tumor data for comparative analysis.

What this research studies

Researchers will build and study mouse models of lung cancer that become resistant to osimertinib and form brain metastases. They will use single-cell RNA sequencing to characterize how resistant tumors behave at the cellular level and compare findings with patient data. The work will connect patient tumor information with animal models to uncover shared pathways that drive resistance and spread, with the goal of identifying new targets for therapy.

Why it matters

Potential benefit: If successful, the work could reveal why resistance occurs and point to new treatment strategies to prevent or treat brain metastases in NSCLC.

How similar studies have gone: Preclinical models of targeted therapy resistance have informed treatment approaches in other cancers, but specific osimertinib-resistance brain metastasis models are not yet established.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Wettersten, Hiromi Inoue — University of California, San Diego
  • Study coordinator: Wettersten, Hiromi Inoue

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.